tpi 1100
Nucleic acidexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2009 (NCT00914433)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Phosphodiesterase 7AANTISENSE INHIBITOR
PDE7A antisense inhibitor
- Phosphodiesterase 4AANTISENSE INHIBITOR
PDE4A antisense inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tpi 1100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00914433 | Phase 1 | Apr 1, 2009 | Syntara, Topigen Pharmaceuticals Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Syntara | For profit | 1 | 1 | 1 | 2009 |
| Topigen Pharmaceuticals Inc. | For profit | 1 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1